Form D · Biotechnology
SEKRIS BIOMEDICAL, INC.
Redlands, CA · CIK 0001584815
Offering snapshot reported Aug 22, 2013 · SEC filing
- Reported sold
- $5K Offering amount: $1.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Aug 8, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 22, 2013 | Initial | $5,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-201724
Issuance of Series A Preferred Stock and underlying Conversion Shares.
Source: Form D, filed Aug 22, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Leonard Bailey | Director |
| Friedrich Kapp | Director |
| Shahrokh Shabahang | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5 E. Citrus Ave., #200
Redlands, CA, 92373
Redlands, CA, 92373